eMultipleSclerosis Review is developed like a "journal club" and provides up-to-date information directly relevant to practice. In each topic-focused newsletter, experts from the Johns Hopkins University School of Medicine and other institutions summarize and provide an expert perspective on the most relevant peer reviewed articles, keeping you up to date on the latest clinical data.
Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.
Barriers To Minority Participation in MS Clinical Trials
In the clinical trials of new MS medications and procedures, why has the participation of racial and ethnic minority individuals been so low? Is it a difficulty with outreach? Are the patient barriers to participation underrecognized and underaddressed? Does historical mistrust of the medical community remain a strong negative? What should clinicians and trial designers do to increase diversity to improve care for all individuals with MS?
Take our post-test (https://elit.dkbmed.com/issues/223/test) to claim CME credits (https://elit.dkbmed.com/issues/223/test)
Read this podcast's companion newsletter here (https://elit.dkbmed.com/issues/221). (https://elit.dkbmed.com/issues/221)
Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.
11 Feb 2025
Treating Sexual & Bladder Dysfunction in Patients with MS
The long-anticipated advances in therapeutic treatments to improve outcomes in both relapsing and progressive MS are coming closer to fruition. Although much of the evidence is still preclinical, the variety and scope of the ongoing research promises to provide new and novel options to manage this disease in the relatively near future.
Take our post-test (https://elit.dkbmed.com/issues/222/test) to claim CME credits (https://elit.dkbmed.com/issues/222/test)
Read this podcast's companion newsletter here (https://elit.dkbmed.com/issues/218). (https://elit.dkbmed.com/issues/218)
Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.
17 Jan 2025
Promising New Options in MS Care
The long-anticipated advances in therapeutic treatments to improve outcomes in both relapsing and progressive MS are coming closer to fruition. Although much of the evidence is still preclinical, the variety and scope of the ongoing research promises to provide new and novel options to manage this disease in the relatively near future.
Take our post-test (https://elit.dkbmed.com/issues/219/test) to claim CME credits (https://elit.dkbmed.com/issues/219/test)
Read this podcast's companion newsletter here (https://elit.dkbmed.com/issues/216). (https://elit.dkbmed.com/issues/216)
Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
2 ratings
Podcast Authority Score: 10 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
8
Social presence
0
YouTube
0
Engagement
32
Contact eMultipleSclerosis Review
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of eMultipleSclerosis Review?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
